2. Vías de señalización
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Produits associés (4399):

Cat. No. Nom du produit Effet Pureté Chemical Structure
  • HY-I0178
    2-Cyanophenothiazine
    		98.91%
    2-Cyanophenothiazine (Phenothiazine-2-carbonitrile) is a drug intermediate for synthesis of various active compounds.
    2-Cyanophenothiazine
  • HY-Y0925
    5-Hexynoic acid
    5-Hexynoic acid (Hex-5-ynoic acid) is an alkynoic acid. 5-Hexynoic acid serves as a drug intermediate for the synthesis of 3-alkoxy-2-cyclohexenone.
    5-Hexynoic acid
  • HY-79986
    Diiodo(p-cymene)ruthenium(II) dimer
    		98.0%
    Diiodo(p-cymene)ruthenium(II) dimer is a drug intermediate for synthesis of various active compounds.
    Diiodo(p-cymene)ruthenium(II) dimer
  • HY-I0046
    4,4-Dimethyl-6-ethynylthiochroman
    		99.78%
    4,4-Dimethyl-6-ethynylthiochroman (Tazarotene Intermediates) is a drug intermediate for synthesis of various active compounds.
    4,4-Dimethyl-6-ethynylthiochroman
  • HY-W390763B
    (S)-6-Methyl-1,4-oxazepan-6-ol hydrochloride
    		99.77%
    (S)-6-Methyl-1,4-oxazepan-6-ol hydrochloride is a drug intermediate for synthesis of various active compounds.
    (S)-6-Methyl-1,4-oxazepan-6-ol hydrochloride
  • HY-20007
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine
    		99.78%
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine is a drug intermediate for synthesis of various active compounds.
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine
  • HY-45448
    4-Chloro-5-nitro-1-tosyl-1H-pyrrolo[2,3-b]pyridine
    		99.90%
    4-Chloro-5-nitro-1-tosyl-1H-pyrrolo[2,3-b]pyridine is a drug intermediate for synthesis of various active compounds.
    4-Chloro-5-nitro-1-tosyl-1H-pyrrolo[2,3-b]pyridine
  • HY-77001
    5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
    		99.99%
    5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid is a drug intermediate for synthesis of various active compounds.
    5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
  • HY-41599
    2-Formylphenoxyacetic acid
    		99.45%
    2-Formylphenoxyacetic acid (2-Carboxymethoxybenzaldehyde) is a drug intermediate for synthesis of various active compounds.
    2-Formylphenoxyacetic acid
  • HY-59137
    1-Methylimidazole
    		99.99%
    1-Methylimidazole acts as a membrane performance regulator that promotes the formation of reverse osmosis membranes with a dense ultra-thin polyamide layer. Such membranes exhibit higher flux and salt rejection rate, while also conferring excellent pH stability to the membrane. 1-Methylimidazole can serve as a ligand for ruthenium (II) complexes to construct metal-based anticancer agents.
    1-Methylimidazole
  • HY-76039
    3-(3-Trifluoromethylphenyl)propanol
    		99.98%
    3-(3-Trifluoromethylphenyl)propanol is a drug intermediate for synthesis of various active compounds.
    3-(3-Trifluoromethylphenyl)propanol
  • HY-W106164A
    ((2S,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol
    		99.40%
    ((2S,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol is a drug intermediate for synthesis of various active compounds.
    ((2S,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol
  • HY-W095670
    2,4,7-Trichloro-8-fluoropyrido[4,3-d]pyrimidine
    		99.95%
    2,4,7-Trichloro-8-fluoropyridopyrimidine is a pyridopyrimidine synthetic intermediate of MRTX1133 (HY-134813), which can be used for the synthesis of non-covalent KRASG12D inhibitors.
    2,4,7-Trichloro-8-fluoropyrido[4,3-d]pyrimidine
  • HY-78334
    4-Aminobenzo-12-crown-4
    		98.0%
    4-Aminobenzo-12-crown-4 is a drug intermediate for synthesis of various active compounds.
    4-Aminobenzo-12-crown-4
  • HY-W153871
    5-Bromo-6-nitro-1,3-benzodioxole
    		99.53%
    5-Bromo-6-nitro-1,3-benzodioxole is a drug intermediate for synthesis of various active compounds.
    5-Bromo-6-nitro-1,3-benzodioxole
  • HY-34485
    tert-Butyl (1R,5S)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
    		99.98%
    tert-Butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylate is a pharmaceutical intermediate containing a dinitrogen-bridged ring structure, used in the synthesis of various active compounds.
    tert-Butyl (1R,5S)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
  • HY-W010098
    Terephthalic acid
    		99.99%
    Terephthalic acid is an isomer and a precursor of polyester PET, which can be used to make clothing and plastics. Terephthalic acid can be used to build skin tumor models.
    Terephthalic acid
  • HY-40249
    1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester
    		99.82%
    1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester is a drug intermediate that can be used for the preparation of SMARCA bromodomain ligands.
    1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester
  • HY-W010610
    2-Cyclopropylacetic acid
    		99.96%
    2-Cyclopropylacetic acid is a substrate. 2-Cyclopropylacetic acid can produce a ring-opening product, which serves as an important precursor for the preparation of fused-ring molecules.
    2-Cyclopropylacetic acid
  • HY-N8245
    2',3'-cGMP sodium
    		99.28%
    2',3'-cGMP sodium, a cGMP analogue, is an intermediate of RNA catalytic cleavage by binase.
    2',3'-cGMP sodium